4) CRISPR Cas9 – Gene Regulation with dCas9
4) CRISPR Cas9 – Gene Regulation with dCas9
For more information on this topic, please visit:
➜ Knowledge Base: https://goo.gl/rSZuAZ
The CRISPR Cas9 system has revolutionized the field of genetic engineering with its simplicity and versatility. Now, scientists have cleverly created a catalytically dead Cas9 (dCas9) that is able to bind its target with high specificity without cutting any DNA. This new CRISPR Cas9 system expands the field a step further as a novel new tool for reversible gene regulation. As you will learn in this video, dCas9 can act as a modular platform upon which activators or repressors can be easily fused and targeted to the gene of interest.
Connect with us on our social media pages to stay up to date with the latest scientific discoveries:
➜ Facebook: https://goo.gl/hc9KrG
➜ Twitter: https://goo.gl/gGGtT9
➜ LinkedIn: https://goo.gl/kSmbht
➜ Google+: https://goo.gl/5bRNwC
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.